NM_001353694.2:c.4306+20G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001353694.2(TIAM1):​c.4306+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00735 in 1,610,848 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0061 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0075 ( 78 hom. )

Consequence

TIAM1
NM_001353694.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.765

Publications

1 publications found
Variant links:
Genes affected
TIAM1 (HGNC:11805): (TIAM Rac1 associated GEF 1) This gene encodes a RAC1-specific guanine nucleotide exchange factor (GEF). GEFs mediate the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP). The binding of GTP induces a conformational change in RAC1 that allows downstream effectors to bind and transduce a signal. This gene thus regulates RAC1 signaling pathways that affect cell shape, migration, adhesion, growth, survival, and polarity, as well as influencing actin cytoskeletal formation, endocytosis, and membrane trafficking. This gene thus plays an important role in cell invasion, metastasis, and carcinogenesis. In addition to RAC1, the encoded protein activates additional Rho-like GTPases such as CDC42, RAC2, RAC3 and RHOA. This gene encodes multiple protein isoforms that experience a diverse array of intramolecular, protein-protein, and phosphorylation interactions as well as phosphoinositide binding. Both the longer and shorter isoforms have C-terminal Dbl homology (DH) and pleckstrin homology (PH) domains while only the longer isoforms of this gene have the N-terminal myristoylation site and the downstream N-terminal PH domain, ras-binding domain (RBD), and PSD-95/DlgA/ZO-1 (PDZ) domain. [provided by RefSeq, Jul 2017]
TIAM1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with language delay and seizures
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 21-31124502-C-T is Benign according to our data. Variant chr21-31124502-C-T is described in ClinVar as Benign. ClinVar VariationId is 2652582.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00749 (10922/1458578) while in subpopulation MID AF = 0.0275 (122/4444). AF 95% confidence interval is 0.0235. There are 78 homozygotes in GnomAdExome4. There are 5654 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001353694.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TIAM1
NM_001353694.2
MANE Select
c.4306+20G>A
intron
N/ANP_001340623.1Q13009-1
TIAM1
NM_001353688.1
c.4306+20G>A
intron
N/ANP_001340617.1Q13009-1
TIAM1
NM_001353689.1
c.4306+20G>A
intron
N/ANP_001340618.1Q13009-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TIAM1
ENST00000541036.6
TSL:5 MANE Select
c.4306+20G>A
intron
N/AENSP00000441570.2Q13009-1
TIAM1
ENST00000698169.1
c.4326G>Ap.Thr1442Thr
synonymous
Exon 27 of 28ENSP00000513591.1A0A8V8TN84
TIAM1
ENST00000923710.1
c.4384+20G>A
intron
N/AENSP00000593769.1

Frequencies

GnomAD3 genomes
AF:
0.00608
AC:
925
AN:
152152
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00877
Gnomad AMR
AF:
0.0103
Gnomad ASJ
AF:
0.0216
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00952
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00803
Gnomad OTH
AF:
0.0139
GnomAD2 exomes
AF:
0.00772
AC:
1929
AN:
249776
AF XY:
0.00859
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00770
Gnomad ASJ exome
AF:
0.0237
Gnomad EAS exome
AF:
0.0000547
Gnomad FIN exome
AF:
0.000324
Gnomad NFE exome
AF:
0.00864
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
AF:
0.00749
AC:
10922
AN:
1458578
Hom.:
78
Cov.:
30
AF XY:
0.00779
AC XY:
5654
AN XY:
725572
show subpopulations
African (AFR)
AF:
0.00141
AC:
47
AN:
33382
American (AMR)
AF:
0.00846
AC:
377
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
0.0240
AC:
626
AN:
26054
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39618
South Asian (SAS)
AF:
0.0114
AC:
975
AN:
85824
European-Finnish (FIN)
AF:
0.000431
AC:
23
AN:
53378
Middle Eastern (MID)
AF:
0.0275
AC:
122
AN:
4444
European-Non Finnish (NFE)
AF:
0.00736
AC:
8182
AN:
1111174
Other (OTH)
AF:
0.00944
AC:
568
AN:
60162
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
555
1111
1666
2222
2777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00606
AC:
923
AN:
152270
Hom.:
4
Cov.:
32
AF XY:
0.00600
AC XY:
447
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.00120
AC:
50
AN:
41554
American (AMR)
AF:
0.0103
AC:
157
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0216
AC:
75
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00932
AC:
45
AN:
4826
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10614
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.00803
AC:
546
AN:
68018
Other (OTH)
AF:
0.0137
AC:
29
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00866
Hom.:
3
Bravo
AF:
0.00694
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
1.4
DANN
Benign
0.85
PhyloP100
-0.77
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148777323; hg19: chr21-32496820; API